Literature DB >> 34342623

X-Waiver Exemption in the Treatment of Opioid Use Disorder.

Riley D Shearer1, Becky R Ford2, Benjamin A Howell3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34342623      PMCID： PMC9191748          DOI： 10.1001/jama.2021.8267

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   157.335


× No keyword cloud information.
  5 in total

1.  Removing One Barrier to Opioid Use Disorder Treatment: Is It Enough?

Authors:  Melissa B Weimer; Sarah E Wakeman; Richard Saitz
Journal:  JAMA       Date:  2021-03-23       Impact factor: 56.272

Review 2.  Achieving Mental Health Equity: Addictions.

Authors:  Ayana Jordan; Myra L Mathis; Jessica Isom
Journal:  Psychiatr Clin North Am       Date:  2020-09

3.  Association of Racial/Ethnic Segregation With Treatment Capacity for Opioid Use Disorder in Counties in the United States.

Authors:  William C Goedel; Aaron Shapiro; Magdalena Cerdá; Jennifer W Tsai; Scott E Hadland; Brandon D L Marshall
Journal:  JAMA Netw Open       Date:  2020-04-01

4.  Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings.

Authors:  Noa Krawczyk; Arthur Robin Williams; Brendan Saloner; Magdalena Cerdá
Journal:  J Subst Abuse Treat       Date:  2021-02-18

5.  Associations Between Polysubstance Use Patterns and Receipt of Medications for Opioid Use Disorder Among Adults in Treatment for Opioid Use Disorder.

Authors:  Becky R Ford; Gavin Bart; Brian Grahan; Riley D Shearer; Tyler N A Winkelman
Journal:  J Addict Med       Date:  2021-04-01       Impact factor: 4.647
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.